Skip to content
lifestyle.militaryparenting.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
ADC Therapeutics SA
ADC Therapeutics Announces Results From LOTIS-5 Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
June 3, 2026
ADC Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Updates
May 4, 2026
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
May 1, 2026
ADC Therapeutics to Host First Quarter 2026 Financial Results Conference Call on May 4, 2026
April 27, 2026
ADC Therapeutics Announces New Employee Inducement Grant
April 1, 2026